[Technic and results of radiotherapy in early stages of ovarian cancer].

By treating eleven patients with an individual large field therapy adapted to the single stage and subsequent chemotherapy (Leukeran), we obtained an average survival time of 42,6 months (living patients) and 37,6 months (patients died), respectively. Late complications of this therapy were not observed, the tolerance was good. In case of recurrence after this treatment, the reserves of bone marrow seem to be too small to allow an aggressive chemotherapy.